Taragarestrant meglumine
Modify Date: 2025-10-07 16:32:29
Taragarestrant meglumine structure
|
Common Name | Taragarestrant meglumine | ||
|---|---|---|---|---|
| CAS Number | 2446618-18-2 | Molecular Weight | 670.60 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H42Cl2FN3O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Taragarestrant meglumineTaragarestrant (D-0502) meglumine is a potent, orally active and selective estrogen receptor degrader (SERD). Taragarestrant meglumine shows potent activity in various ER+ breast cancer cell lines and xenograft models[1][2]. |
| Name | Taragarestrant meglumine |
|---|
| Description | Taragarestrant (D-0502) meglumine is a potent, orally active and selective estrogen receptor degrader (SERD). Taragarestrant meglumine shows potent activity in various ER+ breast cancer cell lines and xenograft models[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Taragarestrant (D-0502) exhibits superior PK profiles suitable for clinical development[1]. |
| References |
[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical. |
| Molecular Formula | C32H42Cl2FN3O7 |
|---|---|
| Molecular Weight | 670.60 |
| InChIKey | QLOWUROBGXPIGD-DAIKAQOVSA-N |
| SMILES | CC1Cc2c([nH]c3ccccc23)C(c2c(Cl)cc(C=CC(=O)O)cc2Cl)N1CC(C)(C)F.CNCC(O)C(O)C(O)C(O)CO |